|
Method for determining substances transport intensity changes in prevailing directions between blood and non-mineralized organs |
|
IPC classes for russian patent Method for determining substances transport intensity changes in prevailing directions between blood and non-mineralized organs (RU 2297001):
Method for detecting toxic action of oral mucosal interferonotherapy / 2288474
One should daily introduce into oral cavity of inbred mouse BALB/c for about 3-5 d an olive-shaped melted edge of capron fish line of 0.5-2.0 mm diameter impregnated with glycerol-containing preparation of recombinant interferon-α, containing 104-106 IU/ml recombinant human interferon-α, then in a dead mouse it is necessary to determine against an intact mouse the morphofunctional state of hepatocytes, enterocytes, lymphoid tissue of regional lymph nodes to evaluate: the absence of toxic action of oral mucosal interferonotherapy in case of no degenerative alterations in hepatocytes, enterocytes, lymphoid tissue of regional lymph nodes in inbred mouse BALB/c subjected to oral mucosal interferonotherapy; the presence of toxic action of oral mucosal interferonotherapy at availability of degenerative alterations of hepatocytes and/or enterocytes, and/or lymphoid tissue of regional lymph nodes in inbred mouse BALB/c after oral mucosal interferonotherapy. The innovation increases information value of the method suggested.
Identification of transgenic dna sequences in plant material and products made of the same, oligonucleotide kit and bioarray therefor / 2270254
Invention relates to method for detection of typical marker foreign DNA sequences, usable in plant modification, in transgenic plant materials and products made of the same. Claimed identification method includes carrying out of multiplex polymerase chain reaction on the base of DNA isolated from tested material followed by hybridization of fluorescent labeled reaction products on specialized bioarrays. Hybridization data are registered by control and program complex and identification of foreign genes and regulatory zones thereof in tested material is carried out, and obtained results are quantitatively interpreted.
Method for detecting immunoreactive compounds / 2268471
The present innovation deals with one-stage detection of a bound analyte with a conjugate consisted of an analyte-stereospecific compound (anti-analyte) being covalently conjugated with suspensoid particles of water-insoluble dyestuffs, as coumassi R-250, and/or acridine yellow, and/or acridine orange, and/or 2.4-nitrodiphenyl hydrazine, and/or fluorescein. Application of an anti-analyte with a colored suspensoid label in technology for obtaining conjugates for analysis of one-stage covalent binding leads to considerable simplification of synthesis procedure, increased economy, and reproducibility and higher sensitivity of detection systems. Thus, the innovation enables to improve sensitivity and reliability of stereospecific analysis and optimization of technology to obtain reagents applied in this process being necessary for detection (stereospecific conjugates).
The method of determining the direction of transport and metabolic rate between mineralized tissue and contacting the biological fluid / 2242007
The invention relates to medicine and can be used in dentistry, trauma, radiology, biochemistry and pathophysiology
The method for determining the level of circulating autoantibodies in biological fluids / 2240561
The invention relates to medicine, in particular to immunology, and can be used for the diagnosis of autoimmune process
Method of imaging cell death in the body of a mammal subject in vivo / 2228765
The invention relates to medicine, in particular to radiology
The method of therapeutic effects on the body / 2228531
The invention relates to medicine, namely to immunology, and can be used for the treatment of diseases associated with a dysfunction of the immune system
The reagent for diagnosing infections caused by puumala virus / 2218571
The invention relates to diagnostics of virus
Labeled luciferase antibody and a method thereof, a method of performing analysis on specific binding and set for use in the analysis of the specific binding / 2199125
The invention relates to biotechnology, relates to a method of conjugating luciferase with chemical particle, in particular antibody, providing (a) mixing luciferase with one or more components, such as D-luciferin, magnesium ions and ATP, and (b) carrying out the reaction of covalent binding between luciferase and linking reagent using covalently bonding agent, where D - luciferin, magnesium ions and/or adenosine triphosphate present in a quantity sufficient to protect the luciferase activity from inhibition of covalently binding agent
The way to determine the inhibitory effect of substances on the complement / 2195665
The invention relates to medicine, namely to immunology, and relates to a method of determining a direct impact on the functional activity of complement components of various substances, including drugs
Method for detecting immunoreactive compounds / 2268471
The present innovation deals with one-stage detection of a bound analyte with a conjugate consisted of an analyte-stereospecific compound (anti-analyte) being covalently conjugated with suspensoid particles of water-insoluble dyestuffs, as coumassi R-250, and/or acridine yellow, and/or acridine orange, and/or 2.4-nitrodiphenyl hydrazine, and/or fluorescein. Application of an anti-analyte with a colored suspensoid label in technology for obtaining conjugates for analysis of one-stage covalent binding leads to considerable simplification of synthesis procedure, increased economy, and reproducibility and higher sensitivity of detection systems. Thus, the innovation enables to improve sensitivity and reliability of stereospecific analysis and optimization of technology to obtain reagents applied in this process being necessary for detection (stereospecific conjugates).
Identification of transgenic dna sequences in plant material and products made of the same, oligonucleotide kit and bioarray therefor / 2270254
Invention relates to method for detection of typical marker foreign DNA sequences, usable in plant modification, in transgenic plant materials and products made of the same. Claimed identification method includes carrying out of multiplex polymerase chain reaction on the base of DNA isolated from tested material followed by hybridization of fluorescent labeled reaction products on specialized bioarrays. Hybridization data are registered by control and program complex and identification of foreign genes and regulatory zones thereof in tested material is carried out, and obtained results are quantitatively interpreted.
Method for detecting toxic action of oral mucosal interferonotherapy / 2288474
One should daily introduce into oral cavity of inbred mouse BALB/c for about 3-5 d an olive-shaped melted edge of capron fish line of 0.5-2.0 mm diameter impregnated with glycerol-containing preparation of recombinant interferon-α, containing 104-106 IU/ml recombinant human interferon-α, then in a dead mouse it is necessary to determine against an intact mouse the morphofunctional state of hepatocytes, enterocytes, lymphoid tissue of regional lymph nodes to evaluate: the absence of toxic action of oral mucosal interferonotherapy in case of no degenerative alterations in hepatocytes, enterocytes, lymphoid tissue of regional lymph nodes in inbred mouse BALB/c subjected to oral mucosal interferonotherapy; the presence of toxic action of oral mucosal interferonotherapy at availability of degenerative alterations of hepatocytes and/or enterocytes, and/or lymphoid tissue of regional lymph nodes in inbred mouse BALB/c after oral mucosal interferonotherapy. The innovation increases information value of the method suggested.
Method for determining substances transport intensity changes in prevailing directions between blood and non-mineralized organs / 2297001
Method involves introducing radioisotope to animals and further repeatedly determining radioisotope inclusions percent in blood and in and in non-mineralized organs in given time intervals, calculating relative radio-activity RRA for an animal examined at each time as ratio between radioisotope inclusions percent in non-mineralized organs to radioisotope inclusions percent in blood. Then transport intensity is determined in prevailing directions in each examination time by applying RRA difference factor (DFRRA), calculated as difference between the subsequent and previous RRA values. The received values of DFRRA factor changes are interpreted in terms of intensity time fluctuations and radioisotope transport direction for each organ.
Method for diagnosing estrogen- and progesteron-dependent genitalia abnormalities / 2312354
Method involves determining estradiol- and progesterone receptors concentration in mononuclear cells fraction of peripheral blood. The value being greater than 210 and 2050 receptors per cell, estrogen- and progesteron-dependent genitalia abnormalities are diagnosed, respectively.
Method of multyanalite immunoassay with use of microparticles / 2339953
On surface of porous membrane apply the reactionary admixture containing analyte, the first binding molecules bound to detecting substance and specific to analyte, the investigated sample and the particles, not capable to pass through the pores of a membrane covered with the second binding molecules, also specific to analyte, incubate an admixture for formation of a biospecific complex, wash an admixture from not bound reagents and register in a regimen of the time permission phosphorescence signals in spectral ranges of the detecting substances corresponding to a constant of time of attenuation of these substances. Determine the required analyte on a parity of measured phosphorescence signals, thus use on two kinds of the first and second binding molecules, each kind of the first binding molecule is bound to two detecting is long luminescing substances, for example chelate of europium and platinaporphyrine which parity of concentration in each first binding molecule is chosen in advance and corresponds to defined analyte.
Method of multianalytic immune assay with using microparticles / 2379691
Invention refers to biology and medicine, namely to immunodiagnosis. There is offered method of multianalytic immune assay based on immunochemical, genetic and other types of reactions of biospecific binding analyte and ligands. There are mixed various categories of microparticles coated with biospecific reagents for binding of various required analytes and marked with one or more fluorochromes in various concentrations emitting a long-living fluorescence. The analysed sample and biospecific developing reagent marked with a detecting fluorochrome with a short-living fluorescence with its excitation area being outside that of fluorochromes with long-living fluorescence are added to the particle mixture. It is followed with reaction for biospecific complex formation. The prepared biospecific complexes are deposited on a solid-phase carrier. The fluorescence emission of all fluorochromes is excited with emitters in two spectral ranges herewith measuring an amount of long-living fluorescence in a time resolution mode to identify the microparticle and an amount of short-living fluorescence of detecting fluorochrome for measuring concentration of required analytes. Thus the concentration ratio of long fluorescing fluorochromes in microparticles for detecting the same type of analyte is constant, and for determining different types of analytes, the concentration ratio differs at least twice.
Device and method for detecting flourescent marked biological components / 2390024
Device comprises a measuring cavity for receiving and introducing a fluid sample. The measuring cavity has a set fixed thickness not exceeding 170 micrometres. The measuring cavity has a section fit for acquisition of its image. Within the measuring cavity, there is a dry reagent. The reagent contains as a component, a molecule conjugate with phosphor used for binding with biological components and with all other reacting components. The reacting components are soluble and/or suspended in the fluid sample. The method involves mixing of the reagent with the liquid sample to be introduced in the measuring cavity. A section of the sample in the measuring cavity is exposed to electromagnetic radiation of wavelength corresponding to wavelength of phosphor excitation. Phosphor marked biological components are detected through-thickness of the measuring cavity. Further, numerical analysis of the digital image follows to identify the biological components showing phosphor and to determine amounts of the biological components showing phosphor in the sample. The biological components are discernible on the digital image as fluorescing points emitting electromagnetic radiation of wavelength corresponding wavelength of phosphor emission.
Method of cell population discrimination and application thereof / 2397494
There is offered a method of discrimination and calculation of at least two populations of biological elements - carriers of specific signs, probably presented in a sample. The method provides the use of three different probes, each of which is specifically fixed with one of the populations of biological elements which are required to be detected. Each probe itself becomes detectable due to its proper marker, and two different markers specified have two emission spectra containing at least one common part (overlapping emission spectra), and the third one has the emission spectrum which essentially contain no common parts with two others (nonoverlapping spectrum).
Identification of molecules modulating protein-protein interaction / 2476891
Group of inventions refers to methods and systems of analysis based on enzymatic degradation following protein-protein interaction for reporter modulation (activation or inactivation).
|
FIELD: medicine. SUBSTANCE: method involves introducing radioisotope to animals and further repeatedly determining radioisotope inclusions percent in blood and in and in non-mineralized organs in given time intervals, calculating relative radio-activity RRA for an animal examined at each time as ratio between radioisotope inclusions percent in non-mineralized organs to radioisotope inclusions percent in blood. Then transport intensity is determined in prevailing directions in each examination time by applying RRA difference factor (DFRRA), calculated as difference between the subsequent and previous RRA values. The received values of DFRRA factor changes are interpreted in terms of intensity time fluctuations and radioisotope transport direction for each organ. EFFECT: enhanced effectiveness in determining intensity dynamics and prevailing direction of substance transport between non-mineralized organ and blood. 3 dwg, 2 tbl
The invention relates to the field of biology and medicine, can be applied biochemists, physiologists, pathophysiology, experts in laboratory diagnosis, long-term space flights in the state of weightlessness and clinicians. There is a method of determining the direction of transport and metabolic rate between mineralized tissue and contacting the biological fluid, characterized in that the injected radioisotope one pair of experimental animals receiving standard feed, and the second pair of experimental animals treated with sucrose cariogenic diet, determine the % include radioisotopes in mineralized tissue and contacting the biological fluid in a period of 24 h, calculate the relative radioactivity of PR for each animal ORA1, ORA2, ORA3and ORA4by the formula and when the values of PR>1, draw conclusions about the direction of transport of a substance from a biological fluid in mineralized tissue; ORA<1, draw conclusions about the direction of transport of the radioisotope in the opposite direction, and when the PR 1.0, conclude that both directions are balanced among themselves; then for these groups of experimental animals calculates the intensity of transport in the prevailing direction is the situation using the ratio of the difference ORA CU ORAformula CUOR=ORA2ORA1and CUOR=ORA4ORA3; CUORAgreater than zero indicate a +, CUORAless than zero indicate the sign; if the values compare CUORAhave opposite signs, then the higher the intensity of the radioisotope transport of the biological fluid in mineralized tissue will be at CUORAwith a large value regardless of the sign (patent No. 2242007 of the Russian Federation. The method of determining the direction of transport and the state of the metabolism between mineralized tissue and contacting the biological fluid. Petrovich Y.A., roadside R.P., Kitsenko S.M. /Mosk. state medical-dental. University, Publ. 2004, No. 34). However, when performing the methods of the prototype only once compared the intensity and direction of transport of radioactive substances in the prevailing direction between the biological fluid and mineralized tissue after 3 and 24 h for [35Se]methionine or only after 6 and 24 h for [75Se]selenate after injection of a radioactive substance. Using the prototype method is not detected, what happens to the radioisotope before and after the specified time, as well as between the two definitions. Since the tissue of bones and teeth, containing up to 60-90% of mineral components from their mass, hundreds and t is thousands of times different from remineralizing bodies high specificity of the chemical composition, metabolism, permeability, experiments with the definition of the transport of substances in the prevailing direction between the blood and saline bodies cannot testify about what is happening with the transport of substances between the blood and demineralizovannykh bodies. In addition, a single definition proposed in the method prototype is generally impossible to identify possible oppositely directed changes in transport of substances in the prevailing directions between the blood and the bodies. This requires multiple sequential tests for a long time. However, knowledge of possible differences in the intensity of the transport of substances in the prevailing directions between the blood and bodies, with multiple consecutive definitions may submit to the experimenters completely new information about the patterns of transport and metabolism, and clinicians may identify new approaches to diagnosis and treatment of various diseases. In addition, the detection time of the maximum and "targeted" delivery of specific substances, including therapeutic, in a specific organ (or organs) for a long time, and not just within one day, may be important for diagnosis and therapy. The vast majority of practically available to study the connections in the state β emitters3H,14C,32P low energy radiation is completely absorbed by soft tissue thickness up to 1-3 mm, and only a few available connections marked γ-emitters radiation which penetrates from the deep layers through tissue located more superficially. In addition, γscan cannot replace our proposed method because it determines the total radiation of different organs and blood, and not separately for blood and organ, as in our method. Object of the invention is the determination of the difference in intensity of the transport of substances in the prevailing directions between the blood and the bodies that should improve the objectivity of research due to multiple definitions in the blood and in the organs of radioactive or non-radioactive substances for a long time after its introduction experimental animals. This is achieved by the fact that the group of animals once intraperitoneally injected radioisotope, after different times of rats consistently derive from experience, calculate the % include label in the blood and demineralization organ (e.g. liver or kidney), calculate the relative radioactivity (ORA) blood/demineralizovannykh body by formula 1: , then calculate the intensity of the transport side is dominant directions using the ratio of the difference of PR (CU ORAthe formula 2: KPOR=ORA2ORA1, CUOR=ORA3ORA2, CUOR=ORA4ORA3etc.; CUORAabove the zero line when the numeric value of the following ORA greater than the previous one, in a given period of time between their definitions is dominated by the transport of the radioisotope from the blood into the body, or when the numerical value of the following ORA lower than the previous one, is dominated by the transport of the radioisotope in the opposite direction; CUORAbelow the zero line when the numeric value of the following ORA is still lower than the previous one, is dominated by the transport of the radioisotope from the body in the blood, or when the numerical value of the following ORA higher than the previous one, is dominated by the transport of the radioisotope in the opposite direction; a greattraffic radioisotopewill be at a higher difference values of the two closest CUORA; the difference in the intensity of transport is calculated when comparing the values of the two nearest CUORAwith the same signs (+or -)by subtracting the value of the smaller CUORAfrom a larger CUORA; when comparing the values of two CUORAwith different signs summarize their values; similarly to the way youapplied in the study of traffic between the blood and mineralizovannyh and bodies, as well as in observations with non-radioactive substances. Presents a new method allows to determine the difference in the intensity and rhythm fluctuations of the transport flows of substances in the prevailing directions between the blood and the body and quantitatively to characterize him. The method is as follows: group of animals once intraperitoneally injected radioisotope, after different times of rats consistently derive from experience, calculate the % include label in the blood and demineralization organ (e.g. liver or kidney), calculate the relative radioactivity (ORA) blood/demineralizovannykh body by formula 1: then calculate the intensity of transport in the prevailing direction using the ratio of the difference of PR (CUORAthe formula 2: CUOR=ORA2ORA1, CUOR=ORA3ORA2, CUOR=ORA4ORA3and so on; then for each term of study determines the rate of transport in the prevailing direction using the ratio of the difference of PR (CUORA), calculated as the difference between the next and previous values of PR. Change the obtained values of the coefficient of CUORAdetermine temporal variations of intensity and direction of transport of the radioisotope is for every body. Depending on the objectives of the study can increase the number of studied organs, methods of analysis and animal per period of time, and also change the duration and the number of intervals between definitions. Research % inclusion, ORA, CUORAand differences in the intensity of transport after injection of [75Se]selenate shown in examples 1, 2 with the liver and examples 3, 4 kidney, and figure 1 of [75Se]selenate was administered to rats one month and three months of age intraperitoneally based 20000 counts/min per 1 g of the weight of the animal. Example 1. Changes fluctuations CUORAliver/blood in rats months of age (table 1, figure 1) had the appearance of three-hump curve. CUORAfrom inception to 1 h was +7,5, from 1 to 3 h decreased to +2, from 3 to 6 h increased slightly to almost +2,5, 6 to 12 h plummeted to -5,6, from 12 to 24 h returned to subprojectname value +0,36, from 24 to 48 h again fell sharply below -4, 48 h and 192 h increased to -0,78. Example 2 (table 1, figure 2). The three-month rats fluctuations CUORAliver/blood were two humps. From inception to 1 h CUORAdramatically upgraded to +9, with 1 to 3 h and 3 to 6 h significantly reduced almost to -7, in the period from 6 to 12 h increased to +4, and gradually reduced to -1 to the end of the experiment. Example 3 (table 1, figure 1). At the month-old rats curve fluctuations CUORAkidney/blood also what had been the three humps. From 0 to 3 h values was +3,53 - +3,39, from 3 to 6 h sharp decline to -1,30, from 6 to 12 h large increase to +2,2, and from 12 to 24 hours more a sharp decline to -4,4, from 24 to 48 h again increased to +2 and 48 h and up to 192 h again a significant reduction to -2,76. Example 4 (table 1, figure 1). Two-humped fluctuations CUORAkidney/blood from a three-month rats also had the opposite directional variations, but with a different rhythm of transport. To 1 h after injection75Se CUORAabove +3,0, then from 1 to 3 h moderate decrease to +1.5, and a sharp decrease to -4 from 3 to 6 hours, alternating significant rise to +5,5 6 to 12 hours, then 12 hours until the end of the experiment, a gradual decrease to almost-2. Changes CUORAin the three-month kidneys of rats with 3-6 h before 24-48 h differed from the month of rats at a much slower rate fluctuations. Three-hump curve in the liver and kidneys monthly rats and two in the three-month rats, probably due to more intensive metabolism in young will vozraste than adult rats. Figure 2 is mapped fluctuations age-related changes in differences in the intensity of transport [75Se]selenate, first, between the blood and the liver (A), secondly, between the blood and kidneys (B). The three-month rats in the first half experience a slight increase in the differences in the intensity of transport between the blood and the liver; at the month-old rats in the first half of the experience noted the correspondingly sharp decline, then a significant upturn, and then in two age groups, there is a decrease until the end of the experience. In the kidney in two age groups in the first half of experience has increased differences in the intensity of transport, in the second half of the experience - reduction, but more moderate than in the liver. Figure 3 is mapped fluctuations changes differences in the intensity of the transport of radioactive isotope between the blood and the liver or blood and kidneys at the month-old animals (A), during the whole experience, except for the last interval. They are oppositely directed. The three-month rats (B), on the contrary, in the early and mid experience changes were parallel in the form of lifting and the next lower, and only at the last time they were the opposite. Figure 4 shows % inclusion in the serum and in demineralization body, ORA and CUORA. Clearly visible fluctuations CUORAstarting with 0-1 h and ending 48-192 h after injection, indicated by thin arrows. Bold arrow 4 additionally shows a possible example of the fluctuations of the transport of substances. When the source is CUORAabove the zero line and the greater value of the next CUORAthan the previous one , is dominated by the transport of the radioisotope from the blood into mineralized tissue (A); when the source is CUORAabove zero is the turn and a smaller value of the next CU ORAthan the previous one , is dominated by the transport in the opposite direction (G); if the source is CUORAbelow the zero line and a smaller value of the next CUORAthan the previous one , is dominated by the transport of the radioisotope of mineralized tissue in the blood (B); when the source is CUORAbelow zero and a larger value of the following CUORAthan the previous one , is dominated by the transport of the radioisotope from the blood into mineralized tissue (At). The proposed method for determining the dynamics of changes in the intensity of transport of substances in the prevailing directions between the blood and demineralizovannykh bodies has a high degree of objectivity that allows it to be applied in the experiment and in the clinic to examine the possibility of a "targeted" delivery of radioactive substances or stable substances, which did not exist before in the body, the body for the purpose of diagnosis and treatment. So, for example, quantify the temporal dynamics of PR and CRORAyou can apply when selecting a radioisotope for the differential diagnosis of malignant and benign tumors, when malignant neoplasms and metastases accumulate more radioactive than benign tumors and healthy bodies. Obviously, more suitable for diagnosis and treatment will be a radioisotope with Baltimor ORAdominated by transport from the blood into the body. Thus, in the study of CUORAand differences in the intensity of transport in the prevailing directions between the blood and organs of rats found when comparing the nearest CUORAage differences in their amplitude and frequency. Based on the obtained fundamental information on the physical law of interference fluctuations of different types of waves, it is possible to perform correction of the deficiency of a substance at a specific time in a specific organ with additional introduction of substances so that the maximum concentration after repeated administration of the substance was at the time of its minimum level in the tissue prior to the introduction. The way to determine the dynamics of changes in the intensity of transport of substances in the prevailing directions between the blood and demineralizovannykh bodies, characterized by the fact that animals injected radioisotope, then repeatedly at set intervals to determine percent incorporation of the radioisotope in the blood and in demineralization body, calculate the relative radioactivity of PR for the studied each term animal as the ratio of the % inclusion of the radioisotope in demineralization authority to % inclusion for the sake of the isotope in the blood, then for each term of study determines the rate of transport in the prevailing direction using the ratio of the difference of PR (CUORA), calculated as the difference between the next and previous values of PR, and change the obtained values of the coefficient of CUORAdetermine temporal variations of intensity and direction of transport of the radioisotope for each organ.
|
© 2013-2015 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English. |